Chinese drugmakers targeted by forthcoming U.S. national security legislation are working on sales of some operations ...

Early Medicare data on the Hospital at Home, the nonprofit caught in the Epic-particle antitrust fight, and more.

How supplies of GLP-1 drugs could be at risk as a result of the dockworker strike occurring across the East and Gulf coasts: ...

How Carequality navigates a conflict between Epic and Particle Health carries big implications for the future of health data ...

After demonstrating safety, the brain-computer interface field is now poised to leap from the lab to the real world.

Opinion: Louisiana’s new restrictions on mifepristone and misoprostol threaten to negate the state’s recent gains in maternal ...

Opinion: Universities can achieve their societal mission to advance knowledge and debate while protecting all voices through ...

U.S. health officials have run into obstacles in their efforts to determine whether a Missouri person infected with H5N1 bird ...

Earlier this year, STAT’s Eric Boodman reported the heartbreaking story of how, for decades, doctors have pressured sickle ...

A pair of U.S. lawmakers is urging the FTC to investigate the parent companies of two large PBMs over concerns that patients ...

The leading CPAP device maker's CEO sees 'two tidal waves' of innovation driving more people to the company's devices.

The connectome could help researchers better understand how to treat diseases like Alzheimer's and Parkinson's.